These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8848296)

  • 21. Bovine anaplasmosis and babesiosis in the Lesser Antilles: risk assessment of an unstable epidemiologic situation.
    Camus E; Montenegro-James S
    Vet Res; 1994; 25(2-3):313-7. PubMed ID: 8038806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-immunization of cattle with a vaccine against babesiosis and Lactobacillus casei increases specific IgG1 levels to Babesia bovis and B. bigemina.
    Bautista-Garfias CR; Lozano AR; Martínez CR; Martínez JA; Millán JV; García GR; Castañeda-Arriola R; Aguilar-Figueroa BR
    Parasitol Int; 2015 Oct; 64(5):319-23. PubMed ID: 25936971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
    Figueroa JV; Precigout E; Carcy B; Gorenflot A
    Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a duplex PCR/DNA probe assay to monitor Babesia bovis and Babesia bigemina in cattle during a vaccination trial.
    Figueroa JV; Alvarez JA; Rojas EE; Ramos JA; Mosqueda JJ; Cantó GJ; Vega CA; Buening GM
    Rev Latinoam Microbiol; 1998; 40(1-2):39-44. PubMed ID: 10932733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 26. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
    Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
    Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live vaccines against hemoparasitic diseases in livestock.
    Pipano E
    Vet Parasitol; 1995 Mar; 57(1-3):213-31. PubMed ID: 7597786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of the Anaplasma centralevaccine strain and specific differentiation from Anaplasma marginale in vaccinated and infected cattle.
    Shkap V; Molad T; Fish L; Palmer GH
    Parasitol Res; 2002 Jun; 88(6):546-52. PubMed ID: 12107477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions.
    González EF; Todorovic RA; Thompson KC
    Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological response of cattle to infection with Babesia bigemina and Babesia bovis in southern Africa.
    Bessenger R; Schoeman JH
    Onderstepoort J Vet Res; 1983 Jun; 50(2):115-7. PubMed ID: 6634084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tick-borne diseases in ruminants of Central and Southern Italy: epidemiology and case reports.
    Savini G; Conte A; Semproni G; Scaramozzino P
    Parassitologia; 1999 Sep; 41 Suppl 1():95-100. PubMed ID: 11071553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization against anaplasmosis and babesiosis. Part III. Evaluation of immunization under field conditions in the Cauca River Valley.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Mar; 30(1):43-52. PubMed ID: 442200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of tick-borne diseases in communal cattle reared on sweet and sour rangelands in a semi-arid area of South Africa.
    Marufu MC; Chimonyo M; Dzama K; Mapiye C
    Vet J; 2010 Apr; 184(1):71-6. PubMed ID: 19733490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodiagnosis of and immunoprophylaxis against the haemoparasites Babesia sp. and Anaplasma sp. in domestic animals.
    Wright IG
    Rev Sci Tech; 1990 Jun; 9(2):345-56. PubMed ID: 2132684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Babesia bovis, B. bigemina, Trypanosoma evansi, and Anaplasma marginale antibodies in cattle in southern Egypt.
    Fereig RM; Mohamed SGA; Mahmoud HYAH; AbouLaila MR; Guswanto A; Nguyen TT; Ahmed Mohamed AE; Inoue N; Igarashi I; Nishikawa Y
    Ticks Tick Borne Dis; 2017 Jan; 8(1):125-131. PubMed ID: 27789159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Bos taurus cattle response to Babesia bovis infection.
    Benavides MV; Sacco AM
    Vet Parasitol; 2007 Nov; 150(1-2):54-64. PubMed ID: 17919816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.